Skip to main content
The Egyptian Heart Journal
Fig. 2 | The Egyptian Heart Journal

Fig. 2

From: Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer

Fig. 2

LVEF values measured before and after both antibody drug protocols (LVEF1 T Left ventricular ejection fraction before trastuzumab, LVEF2 T Left ventricular ejection fraction after trastuzumab, LVEF1 ET Left ventricular ejection fraction before trastuzumab emtansine, LVEF2 ET Left ventricular ejection fraction after trastuzumab emtansine)

Back to article page